Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-08

Clinical Trial Update: In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping [NA]

View source ↗

Summary

This trial investigates validating a risk stratification tool and endotyping approach to accurately diagnose beta-lactam allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Drug Allergy | NA | Status: NOT_YET_RECRUITING